PPARG and neoplasm: Several studies have suggested that PPARG inhibits cyclins and CDKs, leading to cell cycle arrest and inhibition of tumor cell proliferation16, while others have indicated its role in maintaining stem cell viability and its association with brain metastasis in HER2-positive breast cancer17,18.